The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Mirpresoc 80 mg Tablets

80 milligram(s) Tablet

Laboratorios LICONSA, S.A.PA1239/017/003

Main Information

Trade NameMirpresoc 80 mg Tablets
Active SubstancesTelmisartan
Strength80 milligram(s)
Dosage FormTablet
Licence HolderLaboratorios LICONSA, S.A.
Licence NumberPA1239/017/003

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA07 telmisartan


Licence Issued26/11/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0049-005-014
Interchangeable List DocumentPDF of Interchangeable List
« Back